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260a Monday, February 9, 2015Besides control groups previously treated or not with AngII (1010M for 50 mi-
nutes), the experimental groups – cells overexpressing one of the recombinant
proteins LacZ/myc-His, LacZ-V5-His, AT1aR-myc-His and ATRAP-V5-His –
were also treated with AngII. Our results showed, as expected, a significant
faster pHi recovery rate in OKP cells treated with AngII (6,54450,8425 min
in untransfected cells; 3,05950,4659 min in untransfected cells with AngII;
2,78450,6104 and 2.64150,3911 min in LacZ/myc-His and LacZ/V5-His
transfected cells with AngII, respectively). Despite our initial hypothesis, we
did not observe a faster pHi recovery rate in OKP cells overexpressing
AT1R-myc-His (3,02650,5445 min), what could be due to lack of expression
of functional recombinant proteins, since the protein size on Western blot was
lower than expected, or consequence of redundant effect on intracellular
signaling. On the other hand, ATRAP overexpression decreased pHi recovery
rate in comparison with the other experimental groups treated with AngII
(4,42350,9867 min). Our results support the hypothesis that ATRAP plays
an inhibitory effect on Ang/AT1R modulation of NHE3.
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Since skeletal muscle-based precursor of cardiomyocytes (SPOC), a stem cell
that potentially differentiates into heart cells, was reported for leg skeletal mus-
cle of mouse [Winitsky et al. (2005) PloS Biol 3(4), e87], we have studied the
environmental conditions, type of muscles, preparation methods which may
allow us to estimate origin of cells and factors to make cells consistently turning
into spontaneous beating cells. In this paper, whether or not satellite cells are
their origin, eitherwhich exogenous factors orwhich pathwayof signal transduc-
tion are required for differentiation to spontaneous beating cells. Medium con-
dition and extracellular matrix to induce cells into spontaneous beating cells
appeared to be different between whole muscle cells and satellite cells.
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The cyclic nucleotides (cNs) cAMP and cGMP regulate the response of cardiac
myocytes to both external and internal stimuli. Distinctly-regulated phosphodi-
esterases (PDEs) control the degradation of these cNs. As a result of their regu-
lation by cNs, PDEs also facilitate communication between the b-adrenergic
and Nitric Oxide (NO)/cGMP/Protein Kinase G (PKG) signaling pathways,
which regulate the synthesis of cAMP and cGMP, respectively. Activation of
the b-adrenergic pathway potentiates cardiac contractility, whereas activation
of the NO/cGMP/PKG pathway reduces it. As a result, the balance between
cNs plays a critical role in regulating contraction. The phenomena where
cAMP influences the dynamics of the cGMP pathway, and vice versa, are
commonly referred to as cN cross-talk. However, the cross-talk response and
the individual role of each PDE isoenzyme in shaping this response remain
to be fully characterized. We have developed a computational model of the
cN cross-talk network that mechanistically integrates the b-adrenergic and
NO/cGMP/PKG pathways via regulation of PDEs by both cNs. The individual
model components and the entire network model replicate experimentally
observed activation-response relationships and temporal dynamics. The model
predicts that under sub-maximal b-adrenergic stimulation, an increase of PDE2
and a decrease of PDE3 cAMP hydrolysis rates under concomitant NO stimu-
lation results in a net cAMP accumulation, leading to the observed NO-
mediated potentiation of Protein Kinase A (PKA) activation. In addition, under
concomitant b-adrenergic stimulation, due to cGMP accumulation from
increased PDE5 and decreased PDE3 cGMP hydrolysis rates, PKG can be
further activated beyond the level achieved under NO alone. By defining cN
cross-talk reactions based on the binding affinity of cNs to specific PDE do-
mains and the associated hydrolysis rates, we pin-pointed the principal mech-
anisms driving the cross-talk response within this non-linear, tightly-coupled
reaction system.
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Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.In the cardiac myocyte, the second messenger cAMP is synthesized by the
b-adrenergic signaling pathway upon sympathetic activation. It activates Pro-
tein Kinase A (PKA) mediated phosphorylation of downstream targets that are
critical to the control of cardiac contractility. The dynamics of cAMP are also
controlled indirectly by cGMP-mediated regulation of phosphodiesterase
(PDE) isoenzymes. It is not yet clear how the cGMP signal is transduced
by the PDEs to regulate cAMP. To better understand this, we have developed
mechanistically detailed models of PDEs 1 - 4, the primary cAMP hydrolyz-
ing PDEs in cardiac myocytes, and integrated them into an existing model of
the b-adrenergic signaling pathway. Our PDE models are based upon exper-
imental studies performed on purified PDE enzymes which show that cyclic
nucleotides (cNs) bind competitively to the domains of PDEs 1, 2, and 3.
PDE4 is regulated by PKA but does not interact appreciably with cGMP.
Our individual PDE models reproduce cAMP hydrolysis rates as regulated
by various cGMP concentrations, and the fully integrated model also repli-
cates experimentally observed cAMP dose-response relationships and tempo-
ral dynamics. Our model shows that PDE2 is critical to the regulation of
cAMP signals, especially during increased stimulation of the b-adrenergic
pathway. In addition, it reveals that high levels of cGMP out-compete
cAMP for catalytic sites of PDEs 1, 2, and 3, and suppress their cAMP hydro-
lysis rates. This leads to a net accumulation of cAMP despite the negative
feedback of the cAMP-driven increases in rate of PDE4-mediated cAMP
hydrolysis. These results provide insights into how PDEs serve as an integra-
tion point for cN signals and how cN interactions regulate b-adrenergic
response.
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Apoptosis leads cardiac dysfunction and heart failure, which are more
frequently in people with diabetes than in the general population. However,
in impaired glucose tolerance (IGT), which characterizes prediabetic state,
apoptosis has not been evaluated in heart. Moreover, although CaMKII is
related with cardiac apoptosis, the connection with IGT is unknown. Thus,
the present study aimed to evaluate apoptosis in IGT heart and its putative
link with CaMKII activity.
IGT was induced by a fructose-rich diet (control, CD; and fructose, FRD; rats
or mice). Echocardiography, biochemical studies, reactive oxygen species
(ROS), Ca2þi measurements, mitochondrial swelling and mitochondria mem-
brane potential measurements were performed.
FRD rats showed decreased contractility and increased hypertrophy (echocardi-
ography) associated with increased CaMKII activity (P-CaMKII 191.6518.3),
and ROS (185.4528.6%) vs CD rats (100%). TUNEL positive nuclei and Bax/
Bcl2 ratio was increased in FRDvsCD rats (273.6539.7%).Mitochondria from
FRD rats showed significantmore swelling (DDO0.3450.05 CD vs 0.5350.03
FRD) and enhancedmembrane depolarization than CDmitochondria.Myocytes
from FRD rats showed a significant increase in sarcoplasmic reticulum (SR)
Ca2þ leak vs CD myocytes. FRD SR-AIP mice (which express the CaMKII
inhibitory peptide [AIP] at the SR membranes) showed less TUNEL positive
nuclei than their matched FRD control mice. FRD control mice co-treated
with the ROS scavenger, tempol, showed less apoptosis than the one induced
by fructose alone. SR Ca2þ leak was also prevented in either FRD SR-AIP
mice or CD mice co-treated with tempol. Mitochondria swelling was also pre-
vented in S2814A mice, which ryanodine receptor (RyR2) cannot be phosphor-
ylated by CaMKII.
The results would indicate that the signaling apoptotic cascade in IGT hearts
involves mitochondria damage by SR Ca2þ leak produced by CaMKII-
dependent phosphorylation of RyR2. CaMKII would be activated by both,
Ca2þ and ROS.
